LCI 1477 (Diethylpropion hydrochloride extended release 75 mg)
Pill imprint LCI 1477 has been identified as Diethylpropion hydrochloride extended release 75 mg.
Diethylpropion is used in the treatment of obesity and belongs to the drug classes anorexiants, CNS stimulants. There is no proven risk in humans during pregnancy. Diethylpropion 75 mg is classified as a Schedule 4 controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- LCI 1477
- Strength:
- 75 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Anorexiants
CNS stimulants - Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- Lannett Company, Inc.
- National Drug Code (NDC):
- 00527-1477
- Inactive Ingredients:
- mannitol
carbomer homopolymer type A
tartaric acid
hypromellose acetate succinate 06081224 (3 mm2/s)
povidone k30
magnesium stearate
More about diethylpropion
Consumer resources
- Other brands: Tenuate, Tenuate Dospan
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
